![Wooden blocks spell the word prostate](https://www.parsemus.org/wp-content/uploads/2020/09/Prostate-shutterstock_1644561982-e1601864460933.jpg)
Interactive Tool: BPH Symptom Score Questionnaire
This tool is for individuals with a prostate who are experiencing lower urinary tract symptoms. It asks about your about your urinary symptoms from BPH and gives you a score based on how severe your symptoms are. Your score on this questionnaire may help you think about if and how you want to treat the problem. The score is called the International Prostate Symptom Score (IPSS) and is based on the American Urological Association (AUA) Symptom Index.1 It is commonly used to screen for, evaluate, track the symptoms of, and suggest management of the symptoms of benign prostatic hyperplasia (BPH).
1McVary KT, et al. (2010). Guideline on the management of benign prostatic hyperplasia (PH). In American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH)., pp. 2-34. Linthicum, MD: American Urological Association Education and Research.
Over the last month, how often have you:
Human Health News
![smartphone detect dementia](https://www.parsemus.org/wp-content/uploads/2024/07/allftd1-300x157.jpg)
How your smartphone could help detect dementia
In an age when smartphones are part of our daily lives, their potential for revolutionizing healthcare continues to expand. For example, a recent study published
![L.R. Fox of NEXT Life Sciences and Elaine Lissner of the Parsemus Foundation](https://www.parsemus.org/wp-content/uploads/2024/07/elaine-fox-2-300x217.jpg)
Passing the Vasalgel torch
Two years ago, the Parsemus Foundation partnered with NEXT Life Sciences to prepare Vasalgel — the non-hormonal, long-lasting, and reversible male contraceptive — for human
![Human heart with blood cells](https://www.parsemus.org/wp-content/uploads/2024/06/shutterstock_2229343555-300x208.jpg)
Intravenous iron therapy improves outcomes for chronic heart failure
The IRONMAN randomized clinical trial reported that treatment with intravenous iron for individuals with heart failure and iron deficiency resulted in a lower risk of
![smartphone detect dementia](https://www.parsemus.org/wp-content/uploads/2024/07/allftd1-300x157.jpg)
How your smartphone could help detect dementia
In an age when smartphones are part of our daily lives, their potential for revolutionizing healthcare continues to expand. For example, a recent study published
![L.R. Fox of NEXT Life Sciences and Elaine Lissner of the Parsemus Foundation](https://www.parsemus.org/wp-content/uploads/2024/07/elaine-fox-2-300x217.jpg)
Passing the Vasalgel torch
Two years ago, the Parsemus Foundation partnered with NEXT Life Sciences to prepare Vasalgel — the non-hormonal, long-lasting, and reversible male contraceptive — for human
![Human heart with blood cells](https://www.parsemus.org/wp-content/uploads/2024/06/shutterstock_2229343555-300x208.jpg)
Intravenous iron therapy improves outcomes for chronic heart failure
The IRONMAN randomized clinical trial reported that treatment with intravenous iron for individuals with heart failure and iron deficiency resulted in a lower risk of
![The latest research on Alzheimer’s disease as shown a puzzle of a human head with pieces flying away](https://www.parsemus.org/wp-content/uploads/2024/05/shutterstock_2289030251-300x200.jpg)
The latest research on Alzheimer’s disease
Early detection and treatment are important to fighting Alzheimer’s disease. Three recent studies offer promising developments in identifying, preventing and potentially treating Alzheimer’s. Blood tests